Stay updated on AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Sign up to get notified when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.

Latest updates to the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page
- ChecktodayChange DetectedA service alert has been added regarding planned maintenance starting July 25th, during which most services will be unavailable for over 24 hours.SummaryDifference4%
- Check7 days agoChange DetectedThe page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest has been deleted.SummaryDifference4%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference4%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.3%
- Check43 days agoChange DetectedThe web page has been updated to announce the modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference6%
- Check72 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.3%
Stay in the know with updates to AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AK104 Dual Checkpoint Blockade in T-cell Lymphoma Clinical Trial page.